Get started
Author

Thomas Bygott

Observed names: Bygott Thomas, Bygott, Thomas, T Bygott, T. Bygott
ORCID: 0009-0004-7017-1929
Observed ORCID: 0009-0004-7017-1929
OpenAlex ID: A5073977297
Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
2021 · Etienne Cavalier, Julien Guiot, et al. · Frontiers in Molecular Biosciences · 44
PDF
Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs
2022 · H. M. Wilson-Robles, T. Bygott, et al. · BMC Veterinary Research · 24
PDF
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
2019 · Qimin Zhou, Roland Andersson, et al. · Translational research · 21
High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm
2018 · Linus Aronsson, Roland Andersson, et al. · Scandinavian Journal of Gastroenterology · 19
PDF
Characterizing circulating nucleosomes in the plasma of dogs with lymphoma
2021 · Christopher Dolan, Tasha Miller, et al. · BMC Veterinary Research · 18
PDF
Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer
2020 · H Wilson-Robles, T Miller, et al. · PLoS ONE · 18
PDF
Serological biomarkers in triage of FIT-positive subjects?
2017 · Hans J. Nielsen, Ib Jarle Christensen, et al. · Scandinavian Journal of Gastroenterology · 13
PDF
Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma
2021 · Heather Wilson-Robles, Tasha Miller, et al. · BMC Veterinary Research · 10
PDF
Characterizing Circulating Nucleosomes in the Plasma of Dogs with Hemangiosarcoma
2021 · Heather Wilson-Robles, Jason Terrell, et al. · Research Square · 2
PDF
Alpha-1-acid glycoprotein 1 (AGP1) as a novel biomarker for pancreatic cancer.
2019 · Qimin Zhou, Roland Andersson, et al. · Journal of Clinical Oncology · 2
Prognostic value of admission H3.1 nucleosome levels in sepsis-associated acute kidney injury: a secondary analysis of the SISPCT randomised clinical trial
2025 · Caroline Neumann, Frank Bloos, et al. · medRxiv · 1
PDF
3O Early stage I solid cancer detection by direct ChIP-seq of short CTCF-protected plasma ctDNA
2026 · A. Retter, D. Pamart, et al. · ESMO Open
PDF
H3.1 Nucleosomes to Predict Renal Replacement Therapy and Mortality in Sepsis—A Secondary Analysis of the SISPCT Randomized Control Trial
2026 · Caroline Neumann, Frank Bloos, et al. · Critical Care Medicine
Direct analysis of transcription factor protected cfDNA in plasma by ChIP-seq: measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy
2026 · Dorian Pamart, Brieuc Cuvelier, et al. · Clinical Epigenetics
Abstract 2428: Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR
2024 · Jacob Micallef, Dorian Pamart, et al. · Cancer Research
133MO Differentiation of malignant and benign lung nodules using epigenetically modified nucleosomes in plasma
2023 · P-H. Chen, T-M. Tsai, et al. · Annals of Oncology
PDF
Works count: 18
Citation count: 172
H-index: 8
I10-index: 8
Year
Topic
Type